Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.
Arthritis Knee Pain Centers
2 followers
Bristol-Myers Squibb
275 followers
NYU Langone Health
34 followers
West Pharmaceutical Services
10 followers
Curia Global
7 followers
AbbVie
294 followers
Navitus Health
6 followers
HistoSonics
5 followers
Xeris Pharmaceuticals
3 followers
Corcept Therapeutics
4 followers
Rocket Pharmaceuticals
4 followers
Explore companies